Pregnancy and child birth are possible even in young females with diseases to be treated with glucocorticoid by controlling disease activity and careful follow-up. There is no description about expectant and nursing mothers in the guide lines for glucocorticoid-induced osteoporosis published in many countries. Obtaining informed consent is more important for understanding the benefit and risk of the pregnancy and child birth during the glucocorticoid treatment in the female patients, to whom getting a child is very meaningful.
Keyphrases
- disease activity
- mental health
- systemic lupus erythematosus
- rheumatoid arthritis
- pregnancy outcomes
- newly diagnosed
- bone mineral density
- preterm birth
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- gestational age
- ejection fraction
- pregnant women
- postmenopausal women
- healthcare
- juvenile idiopathic arthritis
- oxidative stress
- quality improvement
- drug induced
- bone loss